TGF-β signaling pathway as a pharmacological target in liver diseases

被引:33
作者
Zhang, Sen [1 ]
Sun, Wu-Yi [1 ]
Wu, Jing-Jing [1 ]
Wei, Wei [1 ]
机构
[1] Anhui Med Univ, Inst Clin Pharmacol, Key Lab Antiinflammatory & Immune Med, Minist Educ, Hefei 230032, Anhui, Peoples R China
基金
高等学校博士学科点专项科研基金;
关键词
Transforming growth factor beta; Signaling pathway; Liver diseases; Pharmacological target; Targeted drugs; GROWTH-FACTOR-BETA; RECEPTOR KINASE DOMAIN; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; CROSS-TALK; ACTIVIN-A; INHIBITOR; CANCER; FIBROGENESIS; PROGRESSION;
D O I
10.1016/j.phrs.2014.05.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Transforming growth factor beta (TGF-beta) belongs to a class of pleiotropic cytokines that are involved in the processes of embryonic development, wound healing, cell proliferation, and differentiation. Moreover, TGF-beta is also regarded as a central regulator in the pathogenesis and development of various liver diseases because it contributes to almost all of the stages of disease progression. A range of liver cells are considered to secrete TGF-beta ligands and express related receptors and, consequently, play a crucial role in the progression of liver disease via different signal pathways. In this manuscript, we review the role of the TGF-beta signaling pathway in liver disease and the potential of targeting the TGF-beta signaling in the pharmacological treatment of liver diseases. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 57 条
  • [31] Mechanisms of hepatic fibrogenesis
    Lee, Ursula E.
    Friedman, Scott L.
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2011, 25 (02) : 195 - 206
  • [32] Optimization of a dihydropyrrolopyrazole series of transforming growth factor-β type I receptor kinase domain inhibitors:: Discovery of an orally bioavailable transforming growth factor-β receptor type I inhibitor as antitumor agent
    Li, Hong-Yu
    McMillen, William T.
    Heap, Charles R.
    McCann, Denis J.
    Yan, Lei
    Campbell, Robert M.
    Mundla, Sreenivasa R.
    King, Chi-Hsin R.
    Dierks, Elizabeth A.
    Anderson, Bryan D.
    Britt, Karen S.
    Huss, Karen L.
    Voss, Matthew D.
    Wang, Yan
    Clawson, David K.
    Yingling, Jonathan M.
    Sawyer, J. Scott
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (07) : 2302 - 2306
  • [33] Regulation of TGF-β signalling by protein phosphatases
    Liu, Ting
    Feng, Xin-Hua
    [J]. BIOCHEMICAL JOURNAL, 2010, 430 : 191 - 198
  • [34] Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing
    Margadant, Coert
    Sonnenberg, Arnoud
    [J]. EMBO REPORTS, 2010, 11 (02) : 97 - 105
  • [35] Smad phosphoisoform signaling specificity: the right place at the right time
    Matsuzaki, Koichi
    [J]. CARCINOGENESIS, 2011, 32 (11) : 1578 - 1588
  • [36] Evaluation of anti-TGF-β2 antibody as a new postoperative anti-scarring agent in glaucoma surgery
    Mead, AL
    Wong, TTL
    Cordeiro, MF
    Anderson, IK
    Khaw, PT
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (08) : 3394 - 3401
  • [37] Cross-talk between transforming growth factor-β and Wingless/Int pathways in lung development and disease
    Minoo, Parviz
    Li, Changgong
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (06) : 809 - 812
  • [38] TGF-β Signaling Is Often Attenuated during Hepatotumorigenesis, but Is Retained for the Malignancy of Hepatocellular Carcinoma Cells
    Mu, Xiaoxin
    Lin, Shu
    Yang, Junhua
    Chen, Chen
    Chen, Yun
    Herzig, Maryanne C.
    Washburn, Kenneth
    Halff, Glenn A.
    Walter, Christi A.
    Sun, Beicheng
    Sun, Lu-Zhe
    [J]. PLOS ONE, 2013, 8 (05):
  • [39] Non-Smad signaling pathways
    Mu, Yabing
    Gudey, Shyam Kumar
    Landstrom, Marene
    [J]. CELL AND TISSUE RESEARCH, 2012, 347 (01) : 11 - 20
  • [40] Hepatitis B Virus X Protein Shifts Human Hepatic Transforming Growth Factor (TGF)-β Signaling from Tumor Suppression to Oncogenesis in Early Chronic Hepatitis B
    Murata, Miki
    Matsuzaki, Koichi
    Yoshida, Katsunori
    Sekimoto, Go
    Tahashi, Yoshiya
    Mori, Shigeo
    Uemura, Yoshiko
    Sakaida, Noriko
    Fujisawa, Junichi
    Seki, Toshihito
    Kobayashi, Kazuki
    Yokote, Koutaro
    Koike, Kazuhiko
    Okazaki, Kazuichi
    [J]. HEPATOLOGY, 2009, 49 (04) : 1203 - 1217